|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net decrease (increase) in deferred loan costs | |||||
| Accretion (Amortization) of Discounts and Premiums | |||||
| Depreciation | |||||
| Amortization | |||||
| Accretion of discounts on investment securities | |||||
| Amortization of premiums on investment securities | |||||
| Amortization of debt issuance costs | |||||
| Accretion of premiums and discounts on acquired loans, net | |||||
| Amortization of core deposit intangibles | |||||
| Amortization of fair value marks on liabilities assumed | |||||
| Stock-based compensation | |||||
| Provision (credit) for credit losses | |||||
| Provision for credit losses | |||||
| Net realized losses on sales and calls of AFS securities | |||||
| Net loss (gain) on sale and disposal of equipment | |||||
| Net gain on sale of foreclosed assets | |||||
| Net change in equity investments | |||||
| Increase in bank-owned life insurance, net of expenses | |||||
| Gain on proceeds from death benefits | |||||
| Net decrease (increase) in accrued interest receivable and other assets | |||||
| Net (decrease) increase in accrued interest payable and other liabilities | |||||
| Provision (benefit) for deferred income taxes | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Net cash and cash equivalents acquired in acquisition | |||||
| Purchases of available-for-sale investment securities | |||||
| Proceeds from sales or calls of AFS securities | |||||
| Proceeds from calls of HTM securities | |||||
| Proceeds from maturity and principal repayment of AFS securities | |||||
| Proceeds from principal repayments of HTM securities | |||||
| Net increase in loans | |||||
| Proceeds from sale of foreclosed assets | |||||
| Purchases of premises and equipment | |||||
| Purchases of bank owned life insurance | |||||
| FHLB stock purchased | |||||
| Proceeds from sale of premises and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Net increase (decrease) in demand, interest-bearing and savings deposits | |||||
| Net increase (decrease) in time deposits | |||||
| Proceeds from issuance of subordinated debt | |||||
| Proceeds from borrowings from Federal Home Loan Bank | |||||
| Repayments of borrowings to Federal Home Loan Bank | |||||
| Proceeds of issuance of senior debt | |||||
| Proceeds from borrowings from other financial institutions | |||||
| Repayments of borrowings from other financial institutions | |||||
| Repayments of senior debt | |||||
| Purchase and retirement of common stock | |||||
| Proceeds from stock issued under employee stock purchase plan | |||||
| Proceeds from exercise of stock options | |||||
| Cash dividend payments on common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS AT END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes, net of refunds | |||||
| Operating cash flows from operating leases | |||||
| Non-cash investing and financing activities: | |||||
| Unrealized gain on securities available for sale | |||||
| Transfer of securities from AFS to HTM | |||||
| Transfer of unrealized losses on securities from AFS to HTM | |||||
| Loans transferred to foreclosed assets | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Acquisition: | |||||
| Assets acquired | |||||
| Liabilities assumed | |||||
Loading...